Carl Firth
Founder bij ASLAN PHARMACEUTICALS LIMITED
Vermogen: 429 988 $ op 31-03-2024
Profiel
Dr. Carl A.
Firth is a Chief Executive Officer & Director at Aslan Pharmaceuticals Ltd., a Chief Executive Officer & Executive Director at ASLAN Pharmaceuticals Pte Ltd., a Chairman at Aslan Pharmaceuticals Taiwan Ltd.
and an Independent Non-Executive Director at Exploit Technologies Pte Ltd.
He is on the Board of Directors at Aslan Pharmaceuticals Ltd., ASLAN Pharmaceuticals Pte Ltd., Aslan Pharmaceuticals Hong Kong Ltd., Dotbio Pte Ltd., Jaguahr Therapeutics Pte Ltd., Liberty Park Music Pte Ltd.
and Exploit Technologies Pte Ltd.
Dr. Firth was previously employed as an Independent Non-Executive Director by Uni-Bio Science Group Ltd., a Director-Regional Business Development by AstraZeneca PLC, an Independent Non-Executive Director by Hummingbird Bioscience Pte Ltd., and a Head-Asia Healthcare by Merrill Lynch, Pierce, Fenner & Smith, Inc. He received his undergraduate degree from the University of Cambridge, an MBA from London Business School and a doctorate degree from the University of Cambridge.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-04-2024 | 3 495 836 ( 1.01% ) | 429 988 $ | 31-03-2024 |
Actieve functies van Carl Firth
Bedrijven | Functie | Begin |
---|---|---|
ASLAN PHARMACEUTICALS LIMITED | Founder | 01-01-2010 |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Founder | 03-05-2011 |
Exploit Technologies Pte Ltd.
Exploit Technologies Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Exploit Technologies Pte Ltd. operates as intellectual property portfolio company. It is a technology company which transfer arm of the Agency for Science, Technology and Research. Exploit Technologies and is headquartered in Singapore. | Director/Board Member | - |
Aslan Pharmaceuticals Taiwan Ltd.
Aslan Pharmaceuticals Taiwan Ltd. BiotechnologyHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Taiwan Ltd. develops novel medicines. The private company is based in Taipei, Taiwan and was founded in 2014. | Chairman | - |
Aslan Pharmaceuticals Hong Kong Ltd.
Aslan Pharmaceuticals Hong Kong Ltd. Pharmaceuticals: MajorHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Hong Kong Ltd. is a pharmaceutical manufacturing company. The private company is based in Hong Kong, Hong Kong. | Director/Board Member | - |
Liberty Park Music Pte Ltd.
Liberty Park Music Pte Ltd. Internet Software/ServicesTechnology Services Liberty Park Music Pte Ltd. offers online music lessons for various instruments such as piano, guitar, and drums. The private company is based in Singapore, Singapore. The Singaporean company's beginner to advanced lessons are taught through over 100 easy and fun videos, allowing students to learn at their own pace. The company was founded by Carl Aslan Jason Morton Firth and Brandon Wei, with Brandon Wei serving as the CEO since incorporation. | Founder | - |
Dotbio Pte Ltd.
Dotbio Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Dotbio Pte Ltd. was founded in 2017 and is based in Singapore, Singapore. The Singaporean company takes an innovative therapeutic approach towards the ideal treatment by rapidly prototyping multi-functional antibodies to identify molecules with synergistic activity combinations, optimal architectures, and unique mechanisms of action. Dotbio's approach involves the use of its modular dotbody technology platform, its cofi and hot-cofi stabilization technologies, high-throughput miniaturized assays, and data analytics to generate unique therapeutic molecules that target both extracellular and intracellular disease drivers. Dotbio has a pipeline of such molecules. | Director/Board Member | - |
Jaguahr Therapeutics Pte Ltd. | Director/Board Member | - |
Eerdere bekende functies van Carl Firth
Bedrijven | Functie | Einde |
---|---|---|
UNI-BIO SCIENCE GROUP LIMITED | Director/Board Member | 01-11-2017 |
░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Carl Firth
University of Cambridge | Doctorate Degree |
London Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
UNI-BIO SCIENCE GROUP LIMITED | Health Technology |
ASLAN PHARMACEUTICALS LIMITED | Health Technology |
Bedrijven in privébezit | 9 |
---|---|
Exploit Technologies Pte Ltd.
Exploit Technologies Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Exploit Technologies Pte Ltd. operates as intellectual property portfolio company. It is a technology company which transfer arm of the Agency for Science, Technology and Research. Exploit Technologies and is headquartered in Singapore. | Commercial Services |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Aslan Pharmaceuticals Taiwan Ltd.
Aslan Pharmaceuticals Taiwan Ltd. BiotechnologyHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Taiwan Ltd. develops novel medicines. The private company is based in Taipei, Taiwan and was founded in 2014. | Health Technology |
Aslan Pharmaceuticals Hong Kong Ltd.
Aslan Pharmaceuticals Hong Kong Ltd. Pharmaceuticals: MajorHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Hong Kong Ltd. is a pharmaceutical manufacturing company. The private company is based in Hong Kong, Hong Kong. | Health Technology |
Hummingbird Bioscience Pte Ltd.
Hummingbird Bioscience Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Hummingbird Bioscience Pte Ltd. operates as a biotechnology company. It engages in the research and development of novel cancer immuno-therapeutics. The firm develops antibodies against a number of oncology and immuno-oncology targets. The company was founded by Jerome Boyd-Kirkup, Piers Ingram, and Lan Zhang in 2015 and is headquartered in Singapore. | Commercial Services |
Liberty Park Music Pte Ltd.
Liberty Park Music Pte Ltd. Internet Software/ServicesTechnology Services Liberty Park Music Pte Ltd. offers online music lessons for various instruments such as piano, guitar, and drums. The private company is based in Singapore, Singapore. The Singaporean company's beginner to advanced lessons are taught through over 100 easy and fun videos, allowing students to learn at their own pace. The company was founded by Carl Aslan Jason Morton Firth and Brandon Wei, with Brandon Wei serving as the CEO since incorporation. | Technology Services |
Dotbio Pte Ltd.
Dotbio Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Dotbio Pte Ltd. was founded in 2017 and is based in Singapore, Singapore. The Singaporean company takes an innovative therapeutic approach towards the ideal treatment by rapidly prototyping multi-functional antibodies to identify molecules with synergistic activity combinations, optimal architectures, and unique mechanisms of action. Dotbio's approach involves the use of its modular dotbody technology platform, its cofi and hot-cofi stabilization technologies, high-throughput miniaturized assays, and data analytics to generate unique therapeutic molecules that target both extracellular and intracellular disease drivers. Dotbio has a pipeline of such molecules. | Commercial Services |
Jaguahr Therapeutics Pte Ltd. | |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Finance |